Metropolitan Life Insurance Company (MetLife)’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,055
| Closed | -$33.4K | – | 2149 |
|
|
2024
Q1 | $33.4K | Hold |
2,055
| – | – | ﹤0.01% | 1604 |
|
|
2023
Q4 | $14K | Hold |
2,055
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q3 | $11.2K | Hold |
2,055
| – | – | ﹤0.01% | 2163 |
|
|
2023
Q2 | $14K | Hold |
2,055
| – | – | ﹤0.01% | 2116 |
|
|
2023
Q1 | $10.3K | Sell |
2,055
-238
| -10% | -$1.19K | ﹤0.01% | 2151 |
|
|
2022
Q4 | $11.2K | Sell |
2,293
-12
| -0.5% | -$59 | ﹤0.01% | 2251 |
|
|
2022
Q3 | $33.2K | Hold |
2,305
| – | – | ﹤0.01% | 1736 |
|
|
2022
Q2 | $34.9K | Hold |
2,305
| – | – | ﹤0.01% | 1723 |
|
|
2022
Q1 | $27.4K | Sell |
2,305
-7,268
| -76% | -$86.3K | ﹤0.01% | 1934 |
|
|
2021
Q4 | $155K | Hold |
9,573
| – | – | ﹤0.01% | 2202 |
|
|
2021
Q3 | $273K | Buy |
9,573
+140
| +1% | +$4K | ﹤0.01% | 1847 |
|
|
2021
Q2 | $319K | Buy |
9,433
+472
| +5% | +$16K | ﹤0.01% | 1812 |
|
|
2021
Q1 | $271K | Sell |
8,961
-303
| -3% | -$9.16K | ﹤0.01% | 1806 |
|
|
2020
Q4 | $459K | Hold |
9,264
| – | – | 0.01% | 1413 |
|
|
2020
Q3 | $356K | Hold |
9,264
| – | – | 0.01% | 1435 |
|
|
2020
Q2 | $400K | Buy |
9,264
+1,978
| +27% | +$85.5K | 0.01% | 1372 |
|
|
2020
Q1 | $190K | Hold |
7,286
| – | – | ﹤0.01% | 1615 |
|
|
2019
Q4 | $228K | Hold |
7,286
| – | – | ﹤0.01% | 1825 |
|
|
2019
Q3 | $190K | Buy |
7,286
+5,697
| +359% | +$148K | ﹤0.01% | 1915 |
|
|
2019
Q2 | $36.3K | Buy |
+1,589
| New | +$36.3K | ﹤0.01% | 2530 |
|